A recent study suggested that hepatocyte SHP1 might affect peroxisome proliferator–activated receptor gamma- (PPARγ-) mediated hepatic inflammation by presenting obesity-induced NAFLD [15]. The gene discussed is PTPN6; the disease is metabolic dysfunction-associated steatotic liver disease.